Office of Global Health Affairs; Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR), 52751-52752 [2010-21351]

Download as PDF Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Notices GOVT-1, it is subject to the same routine uses set forth for that system by OPM, see OPM/GOVT-1, or any successor OPM system notice that may be published for this system (visit (www.opm.gov) for more information). See also Appendix I for other ways that the Privacy Act permits the FTC to use or disclose system records outside the agency. RETRIEVABILITY: Indexed by employee social security number and name. * * * * * III. FTC Financial Systems of Records * * * * * FTC-III-2 SYSTEM NAME: * Travel Management System–FTC. * * * * WReier-Aviles on DSKGBLS3C1PROD with NOTICES CATEGORIES OF RECORDS IN THE SYSTEM: Names (as they appear on government-issued driver’s licenses or passports), dates of birth, sex, social security numbers, home and/or business phone numbers, home and/or business addresses, vendor ID or other unique 9digit numbers, e-mail addresses, emergency contact information (names, addresses, and phone numbers), credit card information (personal and/or government-issued), and redress numbers. For traveling FTC employees or other individuals (e.g., witnesses) only, additional data may be maintained, such as passport numbers (for international travelers), frequent flyer or other rewards membership numbers, and trip-specific information (travel dates, flight numbers, destinations, accommodations, vehicle rental, miscellaneous expenses claimed). Other types of records covered by this system are set out in the General Services Administration (GSA) Privacy Act system of records notice applicable to this system, GSA/GOVT-4, or any successor system notice for this system. * * * * * Willard K. Tom, General Counsel. [FR Doc. 2010–21318 Filed 8–26–10; 8:45 am] BILLING CODE 6750–01–S VerDate Mar<15>2010 15:33 Aug 26, 2010 Jkt 220001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Notice of Meeting Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science, Office of the President’s Council on Fitness, Sports and Nutrition. ACTION: Notice of meeting. AGENCY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services (DHHS) is hereby giving notice that the President’s Council on Fitness, Sports and Nutrition (PCFSN) will hold a meeting. The meeting will be open to the public. DATES: The meeting will be held on September 14, 2010, from 1:30 p.m. to 5 p.m. ADDRESSES: The George Washington University, 1957 E Street, NW., 7th Floor, Washington, DC. FOR FURTHER INFORMATION CONTACT: Ms. Shellie Pfohl, Executive Director, President’s Council on Fitness, Sports and Nutrition, Tower Building, 1101 Wootton Parkway, Suite 560, Rockville, MD 20852, (240) 276–9866. Information about PCFSN, including details about the upcoming meeting, can be obtained at https://www.fitness.gov and/or by calling (240) 276–9567. SUPPLEMENTARY INFORMATION: On June 23, 2010, the President established Executive Order 13545 to amend Executive Order 13265, dated June 6, 2002. Under Executive Order 13545, direction is given for the scope of the President’s Council on Physical Fitness and Sports to be expanded to recognize that good nutrition goes hand in hand with fitness and sports participation. Executive Order 13545 gives authority for the title of the Council to be revised to include nutrition. The new title is President’s Council on Fitness, Sports and Nutrition (PCFSN). The primary functions of the PCFSN include (1) advising the President, through the Secretary, concerning progress made in carrying out the provisions of Executive Order 13545 and shall recommend to the President, through the Secretary, actions to accelerate progress; (2) advising the Secretary on ways to promote regular physical activity, fitness, sports participation, and good nutrition. Recommendations may address, but are not necessarily limited to, public awareness campaigns; Federal, State, and local physical activity; fitness, sports participation, and nutrition SUMMARY: PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 52751 initiatives; and partnership opportunities between public- and private-sector health promotion entities; (3) functioning as a liaison to relevant State, local, and private entities in order to advise the Secretary regarding opportunities to extend and improve physical activity, fitness, sports, and nutrition programs and services at the local, State, and national levels; and (4) monitoring the need to enhance programs and educational and promotional materials sponsored, overseen, or disseminated by the Council, and shall advise the Secretary, as necessary, concerning such need. In performing its functions, the Council shall take into account the Federal Dietary Guidelines for Americans and the Physical Activity Guidelines for Americans. The PCFSN will hold, at a minimum, one meeting in a calendar year. The meeting will be held to (1) assess ongoing Council activities and (2) discuss and plan future projects and programs. The agenda for the planned meeting is being developed and will be posted at https://www.fitness.gov when it has been finalized. The meeting that is scheduled to be held on September 14, 2010 is open to the public. Every effort will be made to provide reasonable accommodations for persons with disabilities and/or special needs who wish to attend the meeting. Persons with disabilities and/or special needs should call (240) 276–9567 no later than close of business on September 10, 2010, to request accommodations. Members of the public who wish to attend the meeting are asked to pre-register by calling (240) 276–9567. Registration for public attendance must be completed before close of business on September 10, 2010. Dated: August 23, 2010. Shellie Y. Pfohl, Executive Director, President’s Council on Fitness, Sports and Nutrition. [FR Doc. 2010–21348 Filed 8–26–10; 8:45 am] BILLING CODE 4150–35–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of Global Health Affairs; TransAtlantic Task Force on Antimicrobial Resistance (TATFAR) AGENCY: Office of Global Health Affairs, HHS. Notice of public meeting and request for comments. ACTION: The Office of Global Health Affairs is seeking comments and SUMMARY: E:\FR\FM\27AUN1.SGM 27AUN1 WReier-Aviles on DSKGBLS3C1PROD with NOTICES 52752 Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Notices suggestions from the public on the activities of the Trans-Atlantic Taskforce on Antimicrobial Resistance (TATFAR). DATES: A public meeting will be held in Bethesda, MD, on Friday, October 1, 2010 from 1:30 to approximately 4:30 p.m. Persons wishing to participate, including those who wish to make an oral presentation, must register in advance and provide a copy of their presentation by noon Friday, September 24, 2010. Deadline for Registration for all Attendees: All Other Attendees must register by noon, Friday, September 24, 2010. Deadline for Requests for Special Accommodation: Requests for special accommodation should be submitted by noon, Friday, September 17, 2010. ADDRESSES: Meeting Location: The public meeting will be held on the Campus of the National Institutes of Health, 9000 Rockville Pike, Building 31, Wing C, Room 6, Bethesda, MD 20892. Submission of Written Comments: Written comments can be e-mailed to OGHA.OS@HHS.gov or sent via regular mail to Elana Clarke, Office of Global Health Affairs, Switzer Building Room 2319, 330 C Street, SW., Washington, DC 20201. Registration and Special Accommodations: Individuals wishing to participate or who need special accommodations or both must register by contacting Elana Clarke at Elana.Clarke@hhs.gov. See Registration To Attend and/or Participate in the Public Hearing for instructions on how to submit electronic notices of participation. FOR FURTHER INFORMATION CONTACT: Elana Clarke at Elana.Clarke@hhs.gov or 202 260–0443. Registration To Attend and/or Participate in the Public Meeting: To ensure there is sufficient room we ask that you pre-register. If you wish to make an oral presentation during the open public comment period of the hearing, state your intention to present on your registration submission. To register, please send an electronic mail message to Elana.Clarke@hhs.gov by the deadline listed under DATES. Your email should include your name and email address. Please submit a written statement at the time of registration, identifying each focus area you wish to address and the approximate time requested to make your presentation. Organizations should provide this information as well as the names and e-mail addresses of all participants. Registered individuals will VerDate Mar<15>2010 15:33 Aug 26, 2010 Jkt 220001 be notified of the approximate time scheduled for their presentation prior to the meeting. Depending on the number of presentations, HHS may need to limit the time allotted for presentations. SUPPLEMENTARY INFORMATION: and any documentation may be submitted as Adobe PDF, MSWord or Text (.txt) files. Written comments submitted by regular mail should clearly identify ‘‘TATFAR Comments’’ as the subject. 1. Background On November 3, 2009, the United States and the European Union (EU) agreed to establish a task force to focus ‘‘on urgent antimicrobial resistance issues focused on appropriate therapeutic use of antimicrobial drugs in the medical and veterinary communities, prevention of both healthcare- and community-associated drug-resistant infections, and strategies for improving the pipeline of new antimicrobial drugs, which could be better addressed by intensified cooperation.’’ (2009 EU–U.S. Summit Declaration). The TATFAR is made up of government representatives from the U.S. Department of Health and Human Services for the United States and from the European Commission, European Union agencies, and representatives of three EU member states for the EU. Information about the TATFAR is available at: https://ecdc.europa.eu/en/ activities/diseaseprogrammes/TATFAR/ Pages/index.aspx. 3. Building and Security Guidelines 2. Public Comment and Meeting The public meeting process provides an opportunity for the public to become aware of the activities of the TATFAR to date. In addition, OGHA invites written comments and/or oral presentations of interested persons on the three focus areas of the TATFAR as defined in the 2009 EU/US Summit Declaration: • Appropriate therapeutic use of antimicrobial drugs in the medical and veterinary communities, • Prevention of both healthcare- and community-associated drug-resistant infections, and • Strategies for improving the pipeline of new antimicrobial drugs. Comments should identify specific antimicrobial resistance-related activities in these three areas where intensified cooperation between the United States and the European Union could have the most impact, keeping in mind that the work of the TATFAR will be carried out using currently available resources. In particular, input is sought on activities that can be undertaken in the near-term, with a reasonable possibility of completion over the next 12–15 months. Written comments submitted by email should use the following subject line ‘‘TATFAR Comments.’’ Comments PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 The meeting is being held in a Federal government building; therefore, Federal security measures are applicable. In planning your arrival time, please take account of the need to clear security. All visitors must enter through the NIH Gateway Center and must present government-issued photo identification. All persons entering the building must pass through a metal detector. All items brought to HHS are subject to inspection. For more information on NIH security requirements for visitors, please go to: https://www.nih.gov/about/ visitorsecurity.htm. Signed: August 23, 2010. Nils Daulaire, Director, Office of Global Health Affairs. [FR Doc. 2010–21351 Filed 8–26–10; 8:45 am] BILLING CODE 4150–38–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Request for Comments on Synthetic Biology Department of Health and Human Services, Office of Public Health and Science, The Presidential Commission for the Study of Bioethical Issues. ACTION: Notice. AGENCY: The Presidential Commission for the Study of Bioethical Issues is requesting public comment on the emerging science of synthetic biology, including its potential applications and risks, as well as appropriate ethical boundaries to assure that America reaps the benefits of this new technology. DATES: To assure consideration, comments must be received by October 1, 2010. ADDRESSES: Individuals, groups, and organizations interested in commenting on this topic may submit comments by e-mail to info@bioethics.gov or by mail to the following address: Public Commentary, The Presidential Commission for the Study of Bioethical Issues, 1425 New York Ave., NW., Suite C–100, Washington, DC 20005. FOR FURTHER INFORMATION CONTACT: Ms. Diane M. Gianelli, Director of Communications, The Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue, NW., SUMMARY: E:\FR\FM\27AUN1.SGM 27AUN1

Agencies

[Federal Register Volume 75, Number 166 (Friday, August 27, 2010)]
[Notices]
[Pages 52751-52752]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21351]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Office of Global Health Affairs; Trans-Atlantic Task Force on 
Antimicrobial Resistance (TATFAR)

AGENCY: Office of Global Health Affairs, HHS.

ACTION: Notice of public meeting and request for comments.

-----------------------------------------------------------------------

SUMMARY: The Office of Global Health Affairs is seeking comments and

[[Page 52752]]

suggestions from the public on the activities of the Trans-Atlantic 
Taskforce on Antimicrobial Resistance (TATFAR).

DATES: A public meeting will be held in Bethesda, MD, on Friday, 
October 1, 2010 from 1:30 to approximately 4:30 p.m. Persons wishing to 
participate, including those who wish to make an oral presentation, 
must register in advance and provide a copy of their presentation by 
noon Friday, September 24, 2010.
    Deadline for Registration for all Attendees: All Other Attendees 
must register by noon, Friday, September 24, 2010.
    Deadline for Requests for Special Accommodation: Requests for 
special accommodation should be submitted by noon, Friday, September 
17, 2010.

ADDRESSES: Meeting Location: The public meeting will be held on the 
Campus of the National Institutes of Health, 9000 Rockville Pike, 
Building 31, Wing C, Room 6, Bethesda, MD 20892.
    Submission of Written Comments: Written comments can be e-mailed to 
OGHA.OS@HHS.gov or sent via regular mail to Elana Clarke, Office of 
Global Health Affairs, Switzer Building Room 2319, 330 C Street, SW., 
Washington, DC 20201.
    Registration and Special Accommodations: Individuals wishing to 
participate or who need special accommodations or both must register by 
contacting Elana Clarke at Elana.Clarke@hhs.gov. See Registration To 
Attend and/or Participate in the Public Hearing for instructions on how 
to submit electronic notices of participation.

FOR FURTHER INFORMATION CONTACT: Elana Clarke at Elana.Clarke@hhs.gov 
or 202 260-0443.
    Registration To Attend and/or Participate in the Public Meeting: To 
ensure there is sufficient room we ask that you pre-register. If you 
wish to make an oral presentation during the open public comment period 
of the hearing, state your intention to present on your registration 
submission. To register, please send an electronic mail message to 
Elana.Clarke@hhs.gov by the deadline listed under DATES. Your e-mail 
should include your name and e-mail address.
    Please submit a written statement at the time of registration, 
identifying each focus area you wish to address and the approximate 
time requested to make your presentation. Organizations should provide 
this information as well as the names and e-mail addresses of all 
participants. Registered individuals will be notified of the 
approximate time scheduled for their presentation prior to the meeting. 
Depending on the number of presentations, HHS may need to limit the 
time allotted for presentations.

SUPPLEMENTARY INFORMATION: 

1. Background

    On November 3, 2009, the United States and the European Union (EU) 
agreed to establish a task force to focus ``on urgent antimicrobial 
resistance issues focused on appropriate therapeutic use of 
antimicrobial drugs in the medical and veterinary communities, 
prevention of both healthcare- and community-associated drug-resistant 
infections, and strategies for improving the pipeline of new 
antimicrobial drugs, which could be better addressed by intensified 
cooperation.'' (2009 EU-U.S. Summit Declaration).
    The TATFAR is made up of government representatives from the U.S. 
Department of Health and Human Services for the United States and from 
the European Commission, European Union agencies, and representatives 
of three EU member states for the EU. Information about the TATFAR is 
available at: https://ecdc.europa.eu/en/activities/diseaseprogrammes/TATFAR/Pages/index.aspx.

2. Public Comment and Meeting

    The public meeting process provides an opportunity for the public 
to become aware of the activities of the TATFAR to date. In addition, 
OGHA invites written comments and/or oral presentations of interested 
persons on the three focus areas of the TATFAR as defined in the 2009 
EU/US Summit Declaration:
     Appropriate therapeutic use of antimicrobial drugs in the 
medical and veterinary communities,
     Prevention of both healthcare- and community-associated 
drug-resistant infections, and
     Strategies for improving the pipeline of new antimicrobial 
drugs.
    Comments should identify specific antimicrobial resistance-related 
activities in these three areas where intensified cooperation between 
the United States and the European Union could have the most impact, 
keeping in mind that the work of the TATFAR will be carried out using 
currently available resources. In particular, input is sought on 
activities that can be undertaken in the near-term, with a reasonable 
possibility of completion over the next 12-15 months.
    Written comments submitted by e-mail should use the following 
subject line ``TATFAR Comments.'' Comments and any documentation may be 
submitted as Adobe PDF, MSWord or Text (.txt) files. Written comments 
submitted by regular mail should clearly identify ``TATFAR Comments'' 
as the subject.

3. Building and Security Guidelines

    The meeting is being held in a Federal government building; 
therefore, Federal security measures are applicable. In planning your 
arrival time, please take account of the need to clear security. All 
visitors must enter through the NIH Gateway Center and must present 
government-issued photo identification. All persons entering the 
building must pass through a metal detector. All items brought to HHS 
are subject to inspection. For more information on NIH security 
requirements for visitors, please go to: https://www.nih.gov/about/visitorsecurity.htm.

    Signed: August 23, 2010.
Nils Daulaire,
Director, Office of Global Health Affairs.
[FR Doc. 2010-21351 Filed 8-26-10; 8:45 am]
BILLING CODE 4150-38-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.